Does NEBIVOLOL Cause Condition aggravated? 130 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Condition aggravated have been filed in association with NEBIVOLOL (nebivolol). This represents 2.1% of all adverse event reports for NEBIVOLOL.
130
Reports of Condition aggravated with NEBIVOLOL
2.1%
of all NEBIVOLOL reports
10
Deaths
89
Hospitalizations
How Dangerous Is Condition aggravated From NEBIVOLOL?
Of the 130 reports, 10 (7.7%) resulted in death, 89 (68.5%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does NEBIVOLOL Cause?
Hypotension (487)
Drug ineffective (430)
Bradycardia (371)
Dyspnoea (364)
Fall (320)
Acute kidney injury (300)
Dizziness (294)
Off label use (277)
Fatigue (257)
Hypertension (249)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which NEBIVOLOL Alternatives Have Lower Condition aggravated Risk?
NEBIVOLOL vs NECITUMUMAB
NEBIVOLOL vs NEDAPLATIN
NEBIVOLOL vs NEFAZODONE
NEBIVOLOL vs NEFOPAM
NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG